Publication | Open Access

Blockade of complement activation product C5a activity using specific antibody attenuates intestinal damage in trinitrobenzene sulfonic acid induced model of colitis

InflammationMucosal ImmunologyMedicineImmunologyGastroenterologySpecific AntibodyGut BarrierUlcerative ColitisPharmacologyIntestinal DamageTrinitrobenzene Sulfonic Acid